As of 2025-07-13, the Relative Valuation of Talaris Therapeutics Inc (TALS) is (24.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.72 USD, the upside of Talaris Therapeutics Inc based on Relative Valuation is -992.6%.
The range of the Relative Valuation is (23.54) - (32.98) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 18.9x | 13.6x |
| Forward P/E multiples | 13.1x - 21.5x | 14.2x |
| Fair Price | (23.54) - (32.98) | (24.28) |
| Upside | -965.6% - -1312.4% | -992.6% |
| Date | P/E |